AU4558393A - Ovulation inhibitor for hormonal contraception - Google Patents

Ovulation inhibitor for hormonal contraception

Info

Publication number: AU4558393A
Authority: AU; Australia
Prior art keywords: hormonal contraception; ovulation inhibitor; ovulation; inhibitor; contraception
Prior art date: 1992-07-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU45583/93A

Inventor

Marika Ehrlich

Herbert Kuhl

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-24

Filing date

1993-07-26

Publication date

1994-02-14

1993-07-26 Application filed by Individual filed Critical Individual

1994-02-14 Publication of AU4558393A publication Critical patent/AU4558393A/en

Status Abandoned legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU45583/93A 1992-07-24 1993-07-26 Ovulation inhibitor for hormonal contraception Abandoned AU4558393A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE4224534		1992-07-24
DE4224534A DE4224534A1 (en)	1992-07-24	1992-07-24	Anti-ovulation agent for hormonal contraception
PCT/DE1993/000656 WO1994002103A2 (en)	1992-07-24	1993-07-26	Ovulation inhibitor for hormonal contraception

Publications (1)

Publication Number	Publication Date
AU4558393A true AU4558393A (en)	1994-02-14

Family

ID=6464040

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU45583/93A Abandoned AU4558393A (en)	1992-07-24	1993-07-26	Ovulation inhibitor for hormonal contraception

Country Status (6)

Country	Link
EP (1)	EP0651644A1 (en)
JP (1)	JPH07509454A (en)
AU (1)	AU4558393A (en)
CA (1)	CA2140011A1 (en)
DE (1)	DE4224534A1 (en)
WO (1)	WO1994002103A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4429374C1 (en) *	1994-08-12	1996-02-01	Jenapharm Gmbh	Pharmaceutical preparations for contraception / hormone substitution with biogenic estrogen component
DE19504227C2 (en) *	1995-02-09	1999-04-29	Klaus Dr Med Umbreit	Anti-ovulation agent for hormonal contraception
DE19525017A1 (en) *	1995-06-28	1997-01-02	Schering Ag	Pharmaceutical combination preparation, kit and method for hormonal contraception
DE19540253C2 (en) *	1995-10-28	1998-06-04	Jenapharm Gmbh	Multi-phase preparation for contraception based on natural estrogens
WO1998004267A1 (en) *	1996-07-26	1998-02-05	American Home Products Corporation	Progestin/estrogen oral contraceptive
EP1964557B1 (en)	1997-11-10	2013-01-02	Memorial Sloan-Kettering Cancer Center	Process for producing arsenic trioxide formulations
DE10100911A1 (en)	2001-01-11	2002-08-01	Schering Ag	Process for hormone replacement therapy and its dosage form
TR200400183T4 (en) *	2001-05-23	2004-02-23	Pantarhei Bioscience B.V.	Means and methods for hormonal contraception
EP1453521B1 (en)	2001-12-05	2013-09-04	Teva Women's Health, Inc.	Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
AU2004257772B2 (en) *	2003-07-16	2009-12-17	Teva Women's Health, Inc.	Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102004019743B4 (en)	2004-04-20	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Multiphase preparation for contraception based on natural estrogen
DE102004026671A1 (en)	2004-05-28	2005-12-15	Grünenthal GmbH	Dosage form for hormonal contraception
DE102004026670A1 (en)	2004-05-28	2005-12-15	Grünenthal GmbH	Hormonal contraceptive containing a combination of ethinylestradiol and chlormadinone acetate
US20070111975A1 (en)	2004-10-07	2007-05-17	Duramed Pharmaceuticals, Inc.	Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8153616B2 (en)	2005-10-17	2012-04-10	Bayer Pharma Aktiengesellschaft	Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (en)	2006-10-20	2008-06-11	Bayer Schering Pharma Aktiengesellschaft	Application of estradiol valerate or 17ß-estradiol in combination with dienogest for oral therapy to maintain and/or increase the female libido

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4104385C1 (en) *	1991-02-09	1992-08-13	Marika Dr.Med. 6509 Framersheim De Ehrlich

1992
- 1992-07-24 DE DE4224534A patent/DE4224534A1/en not_active Ceased
1993
- 1993-07-26 CA CA002140011A patent/CA2140011A1/en not_active Abandoned
- 1993-07-26 AU AU45583/93A patent/AU4558393A/en not_active Abandoned
- 1993-07-26 JP JP6504082A patent/JPH07509454A/en active Pending
- 1993-07-26 WO PCT/DE1993/000656 patent/WO1994002103A2/en not_active Application Discontinuation
- 1993-07-26 EP EP93915661A patent/EP0651644A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
CA2140011A1 (en)	1994-01-25
EP0651644A1 (en)	1995-05-10
WO1994002103A3 (en)	1994-05-11
WO1994002103A2 (en)	1994-02-03
JPH07509454A (en)	1995-10-19
DE4224534A1 (en)	1994-01-27

Publication	Publication Date	Title
AU4651793A (en)	1994-01-24	Uterine retractor
AU3802493A (en)	1993-09-13	Surgical endoclip
AU3148095A (en)	1996-03-04	Uterine manipulator
AU4995993A (en)	1994-03-03	Surgical retractor
AU3688393A (en)	1993-10-21	Surgical fastener
ZA947572B (en)	1995-09-28	Contraceptive compositions
AU4944093A (en)	1994-04-12	Osteosynthesis aid
AU4558393A (en)	1994-02-14	Ovulation inhibitor for hormonal contraception
AU7835994A (en)	1995-04-10	Device introducing pharmaceuticals into uterine cervix
AU6436496A (en)	1996-10-31	Device for assisting childbirth
AU3282489A (en)	1989-10-16	Intra-uterine pessary
AU7137196A (en)	1997-04-28	Contraceptive device
AU5243996A (en)	1996-12-19	Orthopedic casting tape
AU7749394A (en)	1995-05-18	Methods for inhibiting uterine fibrosis
AU6836896A (en)	1997-03-19	Fertility agent
AU696242B2 (en)	1998-09-03	Packaging case for condoms
AU4708993A (en)	1994-03-15	Antiprogestogen containing contraceptives
AU2770195A (en)	1996-01-04	Release mechanism for cans
AU4894196A (en)	1996-10-08	Intrauterine contraceptive device
AU2812195A (en)	1996-01-19	Inhibitor
AU697487B2 (en)	1998-10-08	Therapeutic agent for ischemic diseases
AU4971193A (en)	1994-03-29	Discharge device
AU5118493A (en)	1994-04-26	Aromatase inhibitor
AU3454793A (en)	1993-09-03	Contraceptive protection means
AU2224292A (en)	1993-10-21	Uterine retractor